Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial

NCT00165048 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

206

Enrollment

OTHER

Sponsor class

Conditions

Cancer of Stomach

Interventions

DRUG: Vioxx (Rofecoxib)

Sponsor

Chinese University of Hong Kong